Unipath tests techno-rhythm method:
This article was originally published in Clinica
A hi-tech version of the rhythm method is recruiting women for trials in Europe. Unipath's (UK) Personal Contraceptive System uses a hand-held monitor to read urine test sticks. The monitor has been nick-named "the sex traffic light" because it indicates fertility status with red and green lights. While one would like to think that all methods of contraception are, ipso facto, personal, Unipath explains that the monitor records a user's hormone levels on a six-month rolling basis, and uses these to personalise its algorithm. The independently- co-ordinated trials will enrol 1,200 women in Germany, Ireland and the UK.
You may also be interested in...
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.